Advertisement

Degenerative Mitral Regurgitation: Assessment, Physical Examination, and Imaging

  • Nina C. WunderlichEmail author
  • Roy Beigel
  • Florian Rader
  • Jennifer Franke
  • Robert J. Siegel
Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • 149 Downloads
Part of the following topical collections:
  1. Topical Collection on Structural Heart Disease

Abstract

Purpose of Review

In this review, we provide a comprehensive approach to assess degenerative mitral regurgitation.

Recent Findings

In the evaluation of MR, it is important to differentiate between primary (degenerative/organic) MR in which an intrinsic mitral valve lesion(s) is responsible for the occurrence of MR and secondary (functional) MR where the mitral valve is structurally normal, but alterations of the left ventricular geometry cause deterioration of the MV apparatus. Advanced imaging modalities, foremost two-dimensional and three-dimensional echocardiography, are essential for this determination.

Summary

In the evaluation of degenerative MR, the exact mechanism, the extent of the disease, associated valve lesions, the grade of mitral regurgitation severity, and hemodynamic consequences require careful assessment in order to provide patients with appropriate monitoring and treatment.

Keywords

Mitral regurgitation Primary mitral regurgitation Degenerative mitral regurgitation Echocardiography Mitral valve prolapse Barlow’s disease Fibroelastic deficiency Papillary muscle rupture 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, Taliercio CP, Taylor CL, et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990;3(1):54–63.PubMedCrossRefGoogle Scholar
  2. 2.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.PubMedCrossRefGoogle Scholar
  3. 3.
    Carpentier A. Cardiac valve surgery—the “French correction”. J Thorac Cardiovasc Surg 1983; 86(3): 323–337.Google Scholar
  4. 4.
    Enriquez-Sarano M, Freeman WK, Tribouilloy CM, Orszulak TA, Khandheria BK, Seward JB, et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol. 1999;34(4):1129–36.PubMedCrossRefGoogle Scholar
  5. 5.
    Monin JL, Dehant P, Roiron C, Monchi M, Tabet JY, Clerc P, et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. J Am Coll Cardiol. 2005;46(2):302–9.PubMedCrossRefGoogle Scholar
  6. 6.
    David TE, Armstrong S, Sun Z, Daniel L. Late results of mitral valve repair for mitral regurgitation due to degenerative disease. Ann Thorac Surg. 1993;56(1):7–12 discussion 3-4.PubMedCrossRefGoogle Scholar
  7. 7.
    Fornes P, Heudes D, Fuzellier JF, Tixier D, Bruneval P, Carpentier A. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol. 1999;8(2):81–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Mills WR, Barber JE, Ratliff NB, Cosgrove DM 3rd, Vesely I, Griffin BP. Biomechanical and echocardiographic characterization of flail mitral leaflet due to myxomatous disease: further evidence for early surgical intervention. Am Heart J. 2004;148(1):144–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Kim S, Kuroda T, Nishinaga M, Yamasawa M, Watanabe S, Mitsuhashi T, et al. Relationship between severity of mitral regurgitation and prognosis of mitral valve prolapse: echocardiographic follow-up study. Am Heart J. 1996;132(2 Pt 1):348–55.PubMedCrossRefGoogle Scholar
  10. 10.
    Avierinos JF, Gersh BJ, Melton LJ 3rd, et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106(11):1355–61.PubMedCrossRefGoogle Scholar
  11. 11.
    Anders S, Said S, Schulz F, Puschel K. Mitral valve prolapse syndrome as cause of sudden death in young adults. Forensic Sci Int. 2007;171(2–3):127–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Chesler E, King RA, Edwards JE. The myxomatous mitral valve and sudden death. Circulation. 1983;67(3):632–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62(3):222–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Aydin A, Adsay BA, Sheikhzadeh S, Keyser B, Rybczynski M, Sondermann C, et al. Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations. PLoS One. 2013;8(12):e81281.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Grigioni F, Enriquez-Sarano M, Ling LH, Bailey KR, Seward JB, Tajik AJ, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34(7):2078–85.PubMedCrossRefGoogle Scholar
  16. 16.
    •• Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2017;135:e1159–e1195. Most current American guidelines. Google Scholar
  17. 17.
    Alpert MA, Mukerji V, Sabeti M, Russell JL, Beitman BD. Mitral valve prolapse, panic disorder, and chest pain. Medi Clin North Am. 1991;75(5):1119–33.CrossRefGoogle Scholar
  18. 18.
    Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg Surgery 2012; 42(4): S1–44.Google Scholar
  19. 19.
    Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Victor SNV. Definition and function of commissures, slits and scallops of the mitral valve: analysis in 100 hearts. Asia Pac J Thorac Cardiovasc Surg. 1994;3:10–6.CrossRefGoogle Scholar
  21. 21.
    Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation. 1987;75(4):756–67.PubMedCrossRefGoogle Scholar
  22. 22.
    Shah PM. Current concepts in mitral valve prolapse—diagnosis and management. J Cardiol. 2010;56(2):125–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Ribeiro CL, Ginefra P, Albanesi Filho FM, Christiani LA, Quaresma JC, Gomes Filho JB. Prevalence of tricuspid and aortic valve prolapse in patients with mitral valve prolapse. Arq Bras Cardiol. 1989;53(5):251–5.PubMedGoogle Scholar
  24. 24.
    Ben Zekry S, Nagueh SF, Little SH, Quinones MA, McCulloch ML, Karanbir S, et al. Comparative accuracy of two- and three-dimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: initial observations. J Am Soc Echocardiogr. 2011;24(10):1079–85.PubMedCrossRefGoogle Scholar
  25. 25.
    • Heo R, Son JW, B OH, et al. Clinical implications of three-dimensional real-time color Doppler transthoracic echocardiography in quantifying mitral regurgitation: a comparison with conventional two-dimensional methods. J Am Soc Echocardiogr 2017. Underlines the importance of new 3D methods to adequately quanify MR severity. Google Scholar
  26. 26.
    Foster GP, Isselbacher EM, Rose GA, Torchiana DF, Akins CW, Picard MH. Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann Thorac Surg. 1998;65(4):1025–31.PubMedCrossRefGoogle Scholar
  27. 27.
    Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802.PubMedCrossRefGoogle Scholar
  28. 28.
    La Canna G, Arendar I, Maisano F, et al. Real-time three-dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am J Cardiol. 2011;107(9):1365–74.PubMedCrossRefGoogle Scholar
  29. 29.
    Grewal J, Mankad S, Freeman WK, Click RL, Suri RM, Abel MD, et al. Real-time three-dimensional transesophageal echocardiography in the intraoperative assessment of mitral valve disease. J Am Soc Echocardiogr. 2009;22(1):34–41.PubMedCrossRefGoogle Scholar
  30. 30.
    Agricola E, Oppizzi M, Pisani M, Maisano F, Margonato A. Accuracy of real-time 3D echocardiography in the evaluation of functional anatomy of mitral regurgitation. Int J Cardiol. 2008;127(3):342–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Macnab A, Jenkins NP, Bridgewater BJ, Hooper TL, Greenhalgh DL, Patrick MR, et al. Three-dimensional echocardiography is superior to multiplane transoesophageal echo in the assessment of regurgitant mitral valve morphology. Eur J Echocardiogr. 2004;5(3):212–22.PubMedCrossRefGoogle Scholar
  32. 32.
    Tsang W, Freed BH, Lang RM. The role of 3-dimensional echocardiography in the diagnosis and management of mitral valve disease: myxomatous valve disease. Cardiol Clin. 2013;31(2):203–15.PubMedCrossRefGoogle Scholar
  33. 33.
    Grewal J, Suri R, Mankad S, Tanaka A, Mahoney DW, Schaff HV, et al. Mitral annular dynamics in myxomatous valve disease: new insights with real-time 3-dimensional echocardiography. Circulation. 2010;121(12):1423–31.PubMedCrossRefGoogle Scholar
  34. 34.
    Lee R, Haluska B, Leung DY, Case C, Mundy J, Marwick TH. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart. 2005;91(11):1407–12.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121(5):692–705.PubMedCrossRefGoogle Scholar
  36. 36.
    Chan KM, Wage R, Symmonds K, et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:61.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Dujardin KS, Enriquez-Sarano M, Bailey KR, Nishimura RA, Seward JB, Tajik AJ. Grading of mitral regurgitation by quantitative Doppler echocardiography: calibration by left ventricular angiography in routine clinical practice. Circulation. 1997;96(10):3409–15.PubMedCrossRefGoogle Scholar
  38. 38.
    Pontone G, Andreini D, Bertella E, et al. Pre-operative CT coronary angiography in patients with mitral valve prolapse referred for surgical repair: comparison of accuracy, radiation dose and cost versus invasive coronary angiography. Int J Cardiol. 2013;167(6):2889–94.PubMedCrossRefGoogle Scholar
  39. 39.
    Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611–44.PubMedCrossRefGoogle Scholar
  40. 40.
    Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–83.PubMedCrossRefGoogle Scholar
  41. 41.
    Grayburn PA, Weissman NJ, Zamorano JL. Quantitation of mitral regurgitation. Circulation. 2012;126(16):2005–17.PubMedCrossRefGoogle Scholar
  42. 42.
    Pu M, Vandervoort PM, Greenberg NL, Powell KA, Griffin BP, Thomas JD. Impact of wall constraint on velocity distribution in proximal flow convergence zone. Implications for color Doppler quantification of mitral regurgitation. J Am Coll Cardiol. 1996;27(3):706–13.PubMedCrossRefGoogle Scholar
  43. 43.
    Enriquez-Sarano M, Sinak LJ, Tajik AJ, Bailey KR, Seward JB. Changes in effective regurgitant orifice throughout systole in patients with mitral valve prolapse. A clinical study using the proximal isovelocity surface area method. Circulation. 1995;92(10):2951–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Schwammenthal E, Chen C, Benning F, Block M, Breithardt G, Levine RA. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation. 1994;90(1):307–22.PubMedCrossRefGoogle Scholar
  45. 45.
    Gaasch WH, John RM, Aurigemma GP. Managing asymptomatic patients with chronic mitral regurgitation. Chest. 1995;108(3):842–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol. 1984;3(4):916–23.PubMedCrossRefGoogle Scholar
  47. 47.
    Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, Krayenbuehl HP. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation. 1987;76(1):59–67.PubMedCrossRefGoogle Scholar
  48. 48.
    Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol. 2009;54(21):1961–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90(2):830–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 1994;24(6):1536–43.PubMedCrossRefGoogle Scholar
  51. 51.
    Lancellotti P, Cosyns B, Zacharakis D, Attena E, van Camp G, Gach O, et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr. 2008;21(12):1331–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Messika-Zeitoun D, Bellamy M, Avierinos JF, Breen J, Eusemann C, Rossi A, et al. Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J. 2007;28(14):1773–81.PubMedCrossRefGoogle Scholar
  53. 53.
    Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015;65(11):1078–88.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Rafique AM, Siegel RJ. Left ventricular size is critical for the echocardiographic assessment of chronic severe mitral regurgitation. J Am Coll Cardiol. 2015;66(13):1519–21.PubMedCrossRefGoogle Scholar
  55. 55.
    Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena HI, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J. 2011;32(6):751–9.PubMedCrossRefGoogle Scholar
  56. 56.
    • Clavel MA, Tribouilloy C, Vanoverschelde JL, Pizarro R, Suri RM, Szymanski C, et al. Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation. J Am Coll Cardiol. 2016;68(12):1297–307 Underlines the importance of additional factors like BNP in the evaluation of MR which may have impaact on the timing of a procedure. PubMedCrossRefGoogle Scholar
  57. 57.
    Johl MM, Malhotra P, Kehl DW, Rader F, Siegel RJ. Natriuretic peptides in the evaluation and management of degenerative mitral regurgitation: a systematic review. Heart. 2017;103:738.1–744.CrossRefGoogle Scholar
  58. 58.
    • Correia PM, Coutinho GF, Branco C, Garcia A, Antunes MJ. Surgical treatment of posterior mitral valve prolapse: towards 100% repair. J Heart Valve Dis. 2015;24(6):752–9 underlines the excellent surgical results in patients with P2 prolapse.PubMedGoogle Scholar
  59. 59.
    Perier P, Hohenberger W, Lakew F, Diegeler A. Prolapse of the posterior leaflet: resect or respect. Ann Cardiothorac Surg. 2015;4(3):273–7.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Mills WR, Barber JE, Skiles JA, Ratliff NB, Cosgrove DM III, Vesely I, et al. Clinical, echocardiographic, and biomechanical differences in mitral valve prolapse affecting one or both leaflets. Am J Cardiol. 2002;89(12):1394–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Cho L, Gillinov AM, Cosgrove DM 3rd, Griffin BP, Garcia MJ. Echocardiographic assessment of the mechanisms of correction of bileaflet prolapse causing mitral regurgitation with only posterior leaflet repair surgery. Am J Cardiol. 2000;86(12):1349–51.PubMedCrossRefGoogle Scholar
  62. 62.
    da Rocha ESJG, Spampinato R, Misfeld M, et al. Barlow’s mitral valve disease: a comparison of neochordal (loop) and edge-to-edge (Alfieri) minimally invasive repair techniques. Ann Thorac Surg. 2015;100(6):2127–33 discussion 33-5.CrossRefGoogle Scholar
  63. 63.
    Lawrie GM, Zoghbi W, Little S, Shah D, Ben-Zekry Z, Earle N, et al. One hundred percent reparability of degenerative mitral regurgitation: intermediate-term results of a dynamic engineered approach. Ann Thorac Surg. 2016;101(2):576–83 discussion 83-4.PubMedCrossRefGoogle Scholar
  64. 64.
    Bourguignon T, Mazine A, Laurin C, Bouchard D, Demers P, Pellerin M. Repair of anterior mitral leaflet prolapse: comparison of mid-term outcomes with chordal transposition and chordal replacement techniques. J Heart Valve Dis. 2016;25(2):187–94.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Nina C. Wunderlich
    • 1
    Email author
  • Roy Beigel
    • 2
  • Florian Rader
    • 3
  • Jennifer Franke
    • 4
  • Robert J. Siegel
    • 3
  1. 1.Cardiovascular Center DarmstadtDarmstadtGermany
  2. 2.The Heart Institute, Sheba Medical Center, and the Sackler School of MedicineTel Aviv UniversityTel AvivIsrael
  3. 3.Cedars-Sinai Medical CenterThe Heart InstituteLos AngelesUSA
  4. 4.Department of CardiologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations